Literature DB >> 24289512

Protocolized Care for Early Septic Shock (ProCESS) statistical analysis plan.

Francis Pike1, Donald M Yealy, John A Kellum, David T Huang, Amber E Barnato, Tammy L Eaton, Derek C Angus, Lisa A Weissfeld.   

Abstract

BACKGROUND: The Protocolized Care for Early Septic Shock study is a randomised, multicentre, prospective, three-arm, parallel-group trial of alternative resuscitation strategies for early septic shock.
OBJECTIVE: To state our analysis plan for trial data.
METHODS: Our plan is to guide data collection and analysis using pre-existing definitions and testing, with local consensus-based efforts where needed. We examine protocolised care (two experimental approaches) and compare this to usual "wild type" care.
RESULTS: Our plan is to address three aims (clinical efficacy, biology of illness and recovery, and costs and cost-effectiveness) and four hypotheses, and we specify rules for handling data and determining outcomes.
CONCLUSION: By using measures to maintain study conduct and analysis rigour, we hope to improve understanding of early septic shock resuscitation and care of patients.

Entities:  

Mesh:

Year:  2013        PMID: 24289512      PMCID: PMC4081520     

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  23 in total

1.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

2.  On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?

Authors:  Heejung Bang; Clarence E Davis
Journal:  Stat Med       Date:  2007-02-28       Impact factor: 2.373

Review 3.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

4.  Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule.

Authors:  Nathan I Shapiro; Richard E Wolfe; Richard B Moore; Eric Smith; Elizabeth Burdick; David W Bates
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

5.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

6.  Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

7.  Multiple imputation for left-censored biomarker data based on Gibbs sampling method.

Authors:  MinJae Lee; Lan Kong; Lisa Weissfeld
Journal:  Stat Med       Date:  2012-02-22       Impact factor: 2.373

8.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Authors:  Edward Abraham; Konrad Reinhart; Steven Opal; Ignace Demeyer; Christopher Doig; Angel López Rodriguez; Richard Beale; Petr Svoboda; Pierre Francois Laterre; Stuart Simon; Bruce Light; Herbert Spapen; Judy Stone; Allan Seibert; Claus Peckelsen; Cathy De Deyne; Russell Postier; Ville Pettilä; Charles L Sprung; Antonio Artigas; Sandra R Percell; Vincent Shu; Christian Zwingelstein; Jeffrey Tobias; Lona Poole; James C Stolzenbach; Abla A Creasey
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

9.  Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Authors:  Derek C Angus; Walter T Linde-Zwirble; Gilles Clermont; Daniel E Ball; Bruce R Basson; E Wesley Ely; Pierre-Francois Laterre; Jean-Louis Vincent; Gordon Bernard; Ben van Hout
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

10.  Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe.

Authors:  David T Huang; Derek C Angus; Amber Barnato; Scott R Gunn; John A Kellum; Diana K Stapleton; Lisa A Weissfeld; Donald M Yealy; Sandra L Peake; Anthony Delaney; Rinaldo Bellomo; Peter Cameron; Alisa Higgins; Anna Holdgate; Belinda Howe; Steven A Webb; Patricia Williams; Tiffany M Osborn; Paul R Mouncey; David A Harrison; Sheila E Harvey; Kathryn M Rowan
Journal:  Intensive Care Med       Date:  2013-08-30       Impact factor: 17.440

View more
  3 in total

1.  A randomized trial of protocol-based care for early septic shock.

Authors:  Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Lisa A Weissfeld; Francis Pike; Thomas Terndrup; Henry E Wang; Peter C Hou; Frank LoVecchio; Michael R Filbin; Nathan I Shapiro; Derek C Angus
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

2.  Early goal-directed therapy vs usual care in the treatment of severe sepsis and septic shock: a systematic review and meta-analysis.

Authors:  Anna Maria Rusconi; Ilaria Bossi; James Geoffrey Lampard; Michael Szava-Kovats; Andrea Bellone; Eddy Lang
Journal:  Intern Emerg Med       Date:  2015-05-16       Impact factor: 3.397

Review 3.  A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

Authors:  D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.